Genmab Current Ratio 2019-2022 | GMAB

Current and historical current ratio for Genmab (GMAB) from 2019 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Genmab current ratio for the three months ending September 30, 2022 was 9.62.
Genmab Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2022-09-30 $3.89B $0.40B 9.62
2022-06-30 $3.65B $0.28B 13.11
2022-03-31 $3.50B $0.20B 17.31
2021-12-31 $3.62B $0.25B 14.50
2021-09-30 $3.48B $0.29B 12.00
2021-06-30 $3.29B $0.22B 15.03
2021-03-31 $3.23B $0.21B 15.42
2020-12-31 $2.88B $0.19B 15.00
2020-09-30 $3.06B $0.36B 8.64
2020-06-30 $2.83B $0.30B 9.53
2020-03-31 $2.08B $0.11B 19.04
2019-12-31 $2.09B $0.14B 14.88
2019-09-30 $1.83B $0.10B 18.72
2019-06-30 $1.18B $0.08B 14.89
2019-03-31 $0.00B 0.00
2018-12-31 $1.18B $0.07B 16.77
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $25.415B $1.349B
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $153.147B 9.34
GSK (GSK) United Kingdom $71.894B 8.95
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.086B 18.92
Ginkgo Bioworks Holdings (DNA) United States $3.531B 0.00
Myovant Sciences (MYOV) United Kingdom $2.613B 0.00
Arcus Biosciences (RCUS) United States $1.618B 24.29
Biohaven (BHVN) United States $1.266B 0.00
Emergent Biosolutions (EBS) United States $0.645B 5.07
ADC Therapeutics SA (ADCT) Switzerland $0.378B 0.00
Ambrx Biopharma (AMAM) United States $0.078B 0.00
Enzo Biochem (ENZ) United States $0.067B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.022B 0.00